This website uses cookies to improve your experience. Learn more about cookies and how to manage them.

Early Career Pharmacologists Advisory Group (ECPAG) update: An introduction to our newest members

Back to Homepage

Published: 24 Nov 2020

It’s really important to the members of the Early Career Pharmacologists Advisory Group (ECPAG) that the group is representative of the early career pharmacologists that we support. As a Trustee, I’m privileged to work with ECPAG’s talented individuals who genuinely care about making a positive and lasting impact on the running of the Society. Allow me to introduce you to those who have most recently joined us.

Hannah Neale

Hannah-Neale-Photo_close-up.jpgHannah graduated with an MSc in Pharmacology in 2018 from the University of Bath, before pursuing a career in pharmacology at Sosei Heptares, a G protein-coupled receptor specialised company, based in Cambridge, where she enjoys in vitro and ex vivo based lab work across multiple drug targets. To keep a healthy balance with her lab work, outside of work, Hannah enjoys baking cakes and cookies, as well as running and cycling.

I’m super excited to join the ECPAG team and hope to encourage more BPS participation and opportunities for researchers from industrial backgrounds. I am keen to highlight to students and early career pharmacologists how beneficial being a BPS member is.


Michael Keith

Michael achieved his Masters in Pharmacology from the University of Bristol in 2019 and is now entering the second year of his PhD after being awarded the BPS’s A J Clark studentship in 2019. His project is based on improving mechanistic understanding of the signalling interplay between anti-platelet drugs on their respective receptor systems.

I wanted to join ECPAG because I worried about early career opportunities during my undergraduate degree. Since then, I have been fortunate with progression in my career and would like to give back.


Brad Hoare

Brad-Hoare-Photo.jpgBrad is a post-doctoral researcher in the molecular pharmacology of G protein-coupled receptors, at the University of Nottingham.

At my first BPS meeting in 2018 I appreciated the benefits that members gain from the Society’s activities. The ECPAG goal to provide a voice for early career members is something which I identify strongly with. At my own career stage, I struggle with uncertainties about job security and career direction. I joined ECPAG because, as a researcher from overseas, I realise the need for a Society which helps to quickly connect researchers who are new to British and European research environments.


Henry Askew Page

Brad-Hoare-Photo.jpgHenry is a final year medical student at St. George’s University of London (SGUL). Having graduated from a Biomedical Sciences degree from SGUL in 2014, Henry decided to defer his post-graduate medical studies and pursue a PhD in Professor Iain Greenwood’s group, investigating the role of chloride channels in smooth muscle. This led him to a short post-doc role in Brant Isakson’s lab at the University of Virginia before restarting medical training in 2018.

Having spent time in academia, and now in a clinical setting, I feel well equipped to represent early career pharmacologists on a wide range of matters.


Our New Partnership

We are currently embarking on a 2-year strategic partnership with the European Laboratory Research and Innovation Group (ELRIG); there are a number of exciting collaborations on the cards that will benefit early career members. ECPAG have invited two new members to support these initiatives, Mark and Claire.

Mark Soave

Mark-Soave-Photo.jpgMark is a Postdoctoral Research Fellow at the University of Nottingham, using biologics and BRET-based approaches to study G protein-coupled receptor organisation and function. He completed his PhD in Molecular Pharmacology, investigating the pharmacology of a monoclonal antibody at the β1-adrenoceptor. Mark was previously the Chair of the Team Science Early Career Researcher Committee at the Centre of Membrane Proteins and Receptors (COMPARE). He has recently become a member of the Early Career Professionals Workgroup for ELRIG.

I’m excited to join ECPAG to strengthen the ties between ELRIG and the BPS and foster new relationships.


Claire Kelly

Clare-Kelly-Photo_resized-(2).jpgClaire is a final year PhD student at the University of Liverpool. Her work focuses on the effect of hypoxia on glioblastoma invasion using in vivo imaging. Claire has been a general committee member of ELRIG and the ELRIG Early Career Professional (ECP) workshop group since 2017.

Being a part of the ELRIG ECP workshop group for the past three years, I have had the opportunity to assist in organising events for researchers in the early stages of their careers, which have been a huge success. The ELRIG/BPS collaboration will enable us to put on even more events, positively impacting ECPs at the start of their careers.


Blog post currently doesn't have any comments.

If you are a British Pharmacological Society member, please sign in to post comments.

Back to Homepage

Published: 24 Nov 2020

About the author

Laura Ajram

Laura works at the Medicines Discovery Catapult as the Programme Manager for the Psychiatry Consortium - a strategic collaboration of research charities and pharmaceutical companies focusing on identifying and validating novel drug targets for psychiatry. Laura has a PhD in Translational Neuropharmacology (Institute of Psychiatry and Eli Lilly & Co) and has research experience in industry, academia and the NHS. Laura is also an Elected Trustee of the British Pharmacological Society.

Related Pages